Ryozo Ohno
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Platelet Disorders and Treatments
- Blood groups and transfusion
-
- Neutropenia and Cancer Infections
Papers in
- Hematology 13
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 4
-
- Peripheral Neuropathies and Disorders 8
- Co-authors
- E. M. Hersh (2 shared papers)Takashi Naoe (4 shared papers)Akihisa Kanamaru (3 shared papers)Yoshiyuki MORISHIMA (2 shared papers)A Hiraoka (1 shared paper)Masahiro Yoshida (1 shared paper)Yoshitaka Saito (1 shared paper)Tohru Kobayashi (1 shared paper)
- Journals
- Blood (4 papers)Journal of Neuroimmunology (3 papers)Annals of the New York Academy of Sciences (3 papers)Acta Neurologica Scandinavica (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Ryozo Ohno
38 papers receiving 511 citations
Peers
Comparison fields: 5 of 62
- Hematology 283
- Oncology 158
- Immunology 88
- Public Health, Environmental and Occupational Health 107
- Genetics 35
Countries citing papers authored by Ryozo Ohno
This map shows the geographic impact of Ryozo Ohno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryozo Ohno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryozo Ohno more than expected).
Fields of papers citing papers by Ryozo Ohno
This network shows the impact of papers produced by Ryozo Ohno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryozo Ohno. The network helps show where Ryozo Ohno may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryozo Ohno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 121 | |
| 2 | No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group. | 1999 | 60 |
| 3 | 1994 | 52 | |
| 4 | 1970 | 47 | |
| 5 | Administration of human urinary colony stimulating factor after bone marrow transplantation. | 1988 | 41 |
| 6 | A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group. | 1993 | 31 |
| 7 | 1984 | 29 | |
| 8 | 1992 | 28 | |
| 9 | [Late phase II clinical study of irinotecan hydrochloride (CPT-11) in the treatment of malignant lymphoma and acute leukemia. The CPT-11 Research Group for Hematological Malignancies]. | 1994 | 18 |
| 10 | 1998 | 14 | |
| 11 | Establishment and characterization of a new human Bence Jones-type myeloma cell line, NOP-2. | 1991 | 12 |
| 12 | L-asparaginase: suppression of the immune response of mice to sheep red blood cells. | 1970 | 11 |
| 13 | 1987 | 10 | |
| 14 | 1986 | 7 | |
| 15 | 1984 | 7 | |
| 16 | 1991 | 7 | |
| 17 | 1987 | 6 | |
| 18 | [An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with hematological malignancies]. | 1994 | 6 |
| 19 | [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma]. | 1999 | 6 |
| 20 | 1987 | 5 |
About Ryozo Ohno
Ryozo Ohno is a scholar working on Hematology, Neurology, Immunology, Genetics and Oncology, having authored 40 papers that have together received 557 indexed citations. Recurring topics across this work include Peripheral Neuropathies and Disorders (8 papers), Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Hematology (283 citations), Oncology (158 citations), Immunology (88 citations), Public Health, Environmental and Occupational Health (107 citations) and Genetics (35 citations). Ryozo Ohno has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include E. M. Hersh, Takashi Naoe, Akihisa Kanamaru, Yoshiyuki MORISHIMA, A Hiraoka, Masahiro Yoshida, Yoshitaka Saito, Tohru Kobayashi, Katsuhiko Hamaguchi and Keizo Horibe. Their work appears in journals such as Blood, Journal of Neuroimmunology, Annals of the New York Academy of Sciences, Acta Neurologica Scandinavica and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.